Methodological Aspects for Preclinical Evaluation of Gadolinium Presence in Brain Tissue: Critical Appraisal and Suggestions for Harmonization—A Joint Initiative

Gadolinium (Gd)-based contrast agents (GBCAs) are pharmaceuticals that have been approved for 30 years and used daily in millions of patients worldwide. Their clinical benefits are indisputable. Recently, unexpected long-term presence of Gd in the brain has been reported by numerous retrospective cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Robert, Philippe, Frenzel, Thomas, Factor, Cécile, Jost, Gregor, Rasschaert, Marlène, Schuetz, Gunnar, Fretellier, Nathalie, Boyken, Janina, Idée, Jean-Marc, Pietsch, Hubertus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6092104/
https://www.ncbi.nlm.nih.gov/pubmed/29659381
http://dx.doi.org/10.1097/RLI.0000000000000467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6092104/
https://www.ncbi.nlm.nih.gov/pubmed/29659381
http://dx.doi.org/10.1097/RLI.0000000000000467

Ejemplares similares